India - English - Central Drugs Standard Control Organization

norris med. - nimesulide,paracetamol - 100,325;mg

India - English - Central Drugs Standard Control Organization

norris med. - ofloxacin,ornidazole - oz sus - 50,125;mg/5ml - 30ml

India - English - Central Drugs Standard Control Organization

norris med. - ofloxacin - tab - 200/400mg

India - English - Central Drugs Standard Control Organization

norris med. - omeprazole,domperidone - cap - 20,10;mg - 10

India - English - Central Drugs Standard Control Organization

norris med. - tizanidine,diclofenac pot.,paracetamol - mr tab - 2,50,325;mg - 10

Australia - English - Department of Health (Therapeutic Goods Administration)

norris 138 pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

medical devices pty limited - 38355 - protection equipment, radiation, apron - personal x-ray protection.

Australia - English - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - 38355 - protection equipment, radiation, apron - a full or half-length apron-like garment intended to shield portions of the body of a patient, operator, or other persons from exposure to radiation during medical procedures.

United States - English - NLM (National Library of Medicine)

stat rx usa - testosterone (unii: 3xmk78s47o) (testosterone - unii:3xmk78s47o) - testosterone 50 mg in 5 g - testim® is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: - primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. these men usually have low serum testosterone levels and gonadotropins (fsh, lh) above the normal range. - hypogonadotropic hypogonadism (congenital or acquired): idiopathic gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. these men have low testosterone serum levels but have gonadotropins in the normal or low range. testim® has not been clinically evaluated in males under 18 years of age. androgens are contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate. testim® is

Australia - English - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 35183 - mattress, bed, general-purpose - the device is a mattress intended for use in hospitals and home healthcare settings.